Jinglei Miao

916 total citations
21 papers, 664 citations indexed

About

Jinglei Miao is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Jinglei Miao has authored 21 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Jinglei Miao's work include Circular RNAs in diseases (6 papers), Cancer-related molecular mechanisms research (6 papers) and MicroRNA in disease regulation (5 papers). Jinglei Miao is often cited by papers focused on Circular RNAs in diseases (6 papers), Cancer-related molecular mechanisms research (6 papers) and MicroRNA in disease regulation (5 papers). Jinglei Miao collaborates with scholars based in China, United States and Australia. Jinglei Miao's co-authors include Weiguo Wang, Shijie Chen, Yuezhan Li, Zhiyu Ding, Chaoyue Zhang, Mousumi Tania, Song Wu, Minghua Hu, Jianlong Wang and Jinsong Li and has published in prestigious journals such as Small, Journal of Cellular Biochemistry and Cell Death and Disease.

In The Last Decade

Jinglei Miao

20 papers receiving 656 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinglei Miao China 13 387 259 85 85 59 21 664
Zhongxiao Lin China 16 620 1.6× 253 1.0× 60 0.7× 119 1.4× 86 1.5× 38 904
Alireza Abhari Iran 15 441 1.1× 231 0.9× 64 0.8× 92 1.1× 40 0.7× 25 738
Suoyuan Li China 11 324 0.8× 195 0.8× 69 0.8× 87 1.0× 86 1.5× 22 556
Yingying Huang China 16 365 0.9× 220 0.8× 153 1.8× 51 0.6× 141 2.4× 56 738
Yitao Ding China 20 434 1.1× 259 1.0× 135 1.6× 111 1.3× 108 1.8× 52 1.3k
Jiali Wei China 16 462 1.2× 335 1.3× 55 0.6× 57 0.7× 44 0.7× 70 880
Shijie Liao China 16 330 0.9× 176 0.7× 169 2.0× 40 0.5× 95 1.6× 69 690
Laijun Song China 18 259 0.7× 154 0.6× 71 0.8× 32 0.4× 52 0.9× 49 711
Deming Xiao China 11 345 0.9× 174 0.7× 59 0.7× 106 1.2× 27 0.5× 23 711

Countries citing papers authored by Jinglei Miao

Since Specialization
Citations

This map shows the geographic impact of Jinglei Miao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinglei Miao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinglei Miao more than expected).

Fields of papers citing papers by Jinglei Miao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinglei Miao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinglei Miao. The network helps show where Jinglei Miao may publish in the future.

Co-authorship network of co-authors of Jinglei Miao

This figure shows the co-authorship network connecting the top 25 collaborators of Jinglei Miao. A scholar is included among the top collaborators of Jinglei Miao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinglei Miao. Jinglei Miao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zeng, Jin, Dong Wang, Zixin Li, et al.. (2025). Development of a prognostic model for osteosarcoma based on macrophage polarization-related genes using machine learning: implications for personalized therapy. Clinical and Experimental Medicine. 25(1). 146–146. 3 indexed citations
2.
Zeng, Jin, Dong Wang, Tao He, et al.. (2025). Mitochondria-targeted MXene@MnO2-TPP nanoheterostructures for synergistic enhancement of sonodynamic therapy and immunotherapy in osteosarcoma. Bioactive Materials. 54. 450–465. 1 indexed citations
3.
Miao, Jinglei, Zhiyu Ding, Yuezhan Li, et al.. (2024). Bruceantinol targeting STAT3 exerts promising antitumor effects in in vitro and in vivo osteosarcoma models. Molecular Carcinogenesis. 63(6). 1133–1145. 2 indexed citations
4.
Miao, Jinglei, et al.. (2024). WTAP-mediated abnormal m6A modification promotes cancer progression by remodeling the tumor microenvironment: bibliometric and database analyses. Translational Cancer Research. 13(2). 952–974. 3 indexed citations
5.
Tan, Wei, Jinpeng Yan, Jun Zhou, et al.. (2024). Single‐Atom Cu Nanozyme‐Loaded Bone Scaffolds for Ferroptosis‐Synergized Mild Photothermal Therapy in Osteosarcoma Treatment. Advanced Healthcare Materials. 13(15). e2304595–e2304595. 21 indexed citations
6.
Tan, Wei, Zhicheng Wang, Jinpeng Yan, et al.. (2023). Magnetic Field Boosts the Transmembrane Transport Efficiency of Magnesium Ions from PLLA Bone Scaffold. Small. 19(40). e2301426–e2301426. 26 indexed citations
7.
Ding, Zhiyu, Yijun Ren, Yuezhan Li, et al.. (2022). An Innovative Prone Position Using a Body-Shape Plaster Bed and Skull Traction for Posterior Cervical Spine Fracture Surgeries. Frontiers in Surgery. 9. 649421–649421.
8.
Li, Yuezhan, Shuang Zhi, Zhiyu Ding, et al.. (2020). lncRNA Xist Regulates Osteoblast Differentiation by Sponging miR-19a-3p in Aging-induced Osteoporosis. Aging and Disease. 11(5). 1058–1058. 67 indexed citations
9.
Li, Yuezhan, Shuang Zhi, Zhiyu Ding, et al.. (2020). WTAP promotes osteosarcoma tumorigenesis by repressing HMBOX1 expression in an m6A-dependent manner. Cell Death and Disease. 11(8). 659–659. 110 indexed citations
10.
Wang, Weiguo, Yuezhan Li, Shuang Zhi, et al.. (2020). LncRNA-ROR/microRNA-185-3p/YAP1 axis exerts function in biological characteristics of osteosarcoma cells. Genomics. 113(1). 450–461. 16 indexed citations
11.
Li, Jinsong, Zhiyu Ding, Yuezhan Li, et al.. (2020). Reactive oxygen species-sensitive thioketal-linked mesoporous silica nanoparticles as drug carrier for effective antibacterial activity. Materials & Design. 195. 109021–109021. 62 indexed citations
12.
Wang, Weiguo, Jinsong Li, Zhiyu Ding, et al.. (2019). Tanshinone I inhibits the growth and metastasis of osteosarcoma via suppressing JAK/STAT3 signalling pathway. Journal of Cellular and Molecular Medicine. 23(9). 6454–6465. 40 indexed citations
13.
Miao, Jinglei, Weiguo Wang, Song Wu, et al.. (2018). miR-194 Suppresses Proliferation and Migration and Promotes Apoptosis of Osteosarcoma Cells by Targeting CDH2. Cellular Physiology and Biochemistry. 45(5). 1966–1974. 34 indexed citations
14.
Wang, Weiguo, Zhengguang Wang, Shijie Chen, Xiaofang Zang, & Jinglei Miao. (2018). Interleukin‐1β/nuclear factor‐κB signaling promotes osteosarcoma cell growth through the microRNA‐181b/phosphatase and tensin homolog axis. Journal of Cellular Biochemistry. 120(2). 1763–1772. 21 indexed citations
15.
Hu, Minghua, et al.. (2017). IL-1β-induced NF-κB activation down-regulates miR-506 expression to promotes osteosarcoma cell growth through JAG1. Biomedicine & Pharmacotherapy. 95. 1147–1155. 75 indexed citations
16.
Miao, Jinglei, et al.. (2013). MicroRNAs in osteosarcoma: diagnostic and therapeutic aspects. Tumor Biology. 34(4). 2093–2098. 108 indexed citations
17.
Miao, Jinglei, et al.. (2012). Genetic abnormalities in Fibrodysplasia Ossificans Progressiva. Genes & Genetic Systems. 87(4). 213–219. 20 indexed citations
18.
Miao, Jinglei, et al.. (2012). [Characteristics and treatment of traumatic cervical disc herniation].. PubMed. 25(10). 817–20. 1 indexed citations
19.
Miao, Jinglei, et al.. (2009). Association of genotypes of the CYP3A cluster with midazolam disposition in vivo. The Pharmacogenomics Journal. 9(5). 319–326. 51 indexed citations
20.
Zhang, Chaoyue, et al.. (2001). Feasibility of endoscopic transoral-transpharyngeal approach to atlantoaxis. Zhonghua guke zazhi. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026